DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 111 filers reported holding DICE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 11.16 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $104,034,301 | -68.0% | 2,239,223 | -80.3% | 0.01% | -40.0% |
Q1 2023 | $325,494,944 | +100.7% | 11,361,080 | +118.6% | 0.02% | -6.2% |
Q4 2022 | $162,157,539 | +133.6% | 5,197,357 | +51.8% | 0.02% | +128.6% |
Q3 2022 | $69,417,000 | +134.1% | 3,422,924 | +79.2% | 0.01% | +133.3% |
Q2 2022 | $29,648,000 | +354.3% | 1,910,328 | +460.0% | 0.00% | +200.0% |
Q1 2022 | $6,526,000 | -34.3% | 341,122 | -13.1% | 0.00% | 0.0% |
Q4 2021 | $9,937,000 | -68.5% | 392,600 | -59.3% | 0.00% | -66.7% |
Q3 2021 | $31,587,000 | – | 964,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Northpond Ventures, LLC | 3,292,871 | $62,993,000 | 33.95% |
Sands Capital Ventures, LLC | 3,148,970 | $60,240,000 | 12.58% |
OUP Management Co., LLC | 536,693 | $10,267,000 | 7.82% |
New Leaf Venture Partners, L.L.C. | 556,693 | $10,650,000 | 5.25% |
Logos Global Management LP | 1,385,251 | $26,500,000 | 3.44% |
Soleus Capital Management, L.P. | 983,994 | $18,824,000 | 2.43% |
RA Capital Management | 5,208,911 | $99,646,000 | 2.17% |
Deep Track Capital, LP | 1,250,000 | $23,913,000 | 1.53% |
Samsara BioCapital, LLC | 228,466 | $4,371,000 | 1.10% |
HighVista Strategies LLC | 48,960 | $937,000 | 0.60% |